SANOFI CONSUMER HEALTHCARE INDIA
|
SANOFI CONSUMER HEALTHCARE INDIA Last 5 Year Cashflow Statement History
[Standalone]
| Dec2025 | Dec2024 | Dec2023 | |
|---|---|---|---|
| Profit Before Tax | ₹320 Cr | ₹247 Cr | ₹219 Cr |
| Adjustment | ₹-4.30 Cr | ₹0.50 Cr | ₹-2.20 Cr |
| Changes In working Capital | ₹-54 Cr | ₹316 Cr | ₹-213 Cr |
| Cash Flow after changes in Working Capital | ₹262 Cr | ₹563 Cr | ₹3.80 Cr |
| Cash Flow from Operating Activities | ₹175 Cr | ₹439 Cr | ₹-0.40 Cr |
| Cash Flow from Investing Activities | ₹7.60 Cr | ₹1.90 Cr | - |
| Cash Flow from Financing Activities | ₹-135 Cr | ₹-116 Cr | ₹2.00 Cr |
| Net Cash Inflow / Outflow | ₹48 Cr | ₹325 Cr | ₹1.60 Cr |
| Opening Cash & Cash Equivalents | ₹327 Cr | ₹1.60 Cr | - |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹375 Cr | ₹327 Cr | ₹1.60 Cr |
Compare Cashflow Statement of peers of SANOFI CONSUMER HEALTHCARE INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANOFI CONSUMER HEALTHCARE INDIA | ₹9,576.2 Cr | -1.4% | -11% | -19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
SANOFI CONSUMER HEALTHCARE INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANOFI CONSUMER HEALTHCARE INDIA | -1.4% |
-11% |
-19.3% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses